Gyon Technologies Capital Management, LP Blueprint Medicines Corp Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$54.1 - $110.08 $1.33 Million - $2.71 Million
-24,642 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$94.25 - $115.99 $390,854 - $481,010
4,147 Added 20.23%
24,642 $2.64 Million
Q3 2021

Nov 18, 2021
BUY
$80.98 - $109.47 $1.66 Million - $2.24 Million
20,495 New
20,495 $2.11 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email